Skip to main content
logo
ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
12.99
-0.25 (-1.89%)
Aug 31, 2026, 4:00 PM EDT - Market closed

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,346797569502265579
Market Cap Growth
35.12%39.89%13.47%89.55%-54.26%-53.31%
Enterprise Value
1,08851730728584302
Last Close Price
12.998.188.079.205.8914.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.532.072.342.241.192.12
P/TBV Ratio
3.532.072.342.241.192.12

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.040.050.050.05
Net Debt / Equity Ratio
-0.68-0.71-1.01-0.88-0.87-0.82
Net Debt / EBITDA Ratio
1.671.931.741.802.262.88
Net Debt / FCF Ratio
2.312.452.172.292.523.71
Quick Ratio
12.7613.7910.3010.1813.4115.64
Current Ratio
13.1914.1310.5610.3913.6815.88
Return on Equity (ROE)
-39.80%-41.27%-54.73%-45.11%-35.98%-27.98%
Return on Assets (ROA)
-25.97%-26.17%-33.95%-27.74%-19.87%-16.50%
Return on Capital Employed (ROCE)
-40.70%-36.80%-57.30%-47.80%-37.40%-27.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.42%-16.25%-22.45%-20.06%-33.66%-13.60%
FCF Yield
-8.34%-14.02%-19.99%-17.24%-29.17%-10.45%
Buyback Yield / Dilution
-43.06%-25.91%-35.52%-29.74%-4.48%-72.97%
SEC Filings: 10-K · 10-Q